These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28938500)

  • 1. Acceptability of two colorectal cancer screening tests: pain as a key determinant in sigmoidoscopy.
    Kirkøen B; Berstad P; Botteri E; Dalén E; Nilsen JA; Hoff G; de Lange T; Bernklev T
    Endoscopy; 2017 Nov; 49(11):1075-1086. PubMed ID: 28938500
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Weissfeld JL; Ling BS; Schoen RE; Bresalier RS; Riley T; Prorok PC;
    Cancer; 2002 May; 94(10):2569-76. PubMed ID: 12173322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
    Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial.
    Randel KR; Schult AL; Botteri E; Hoff G; Bretthauer M; Ursin G; Natvig E; Berstad P; Jørgensen A; Sandvei PK; Olsen ME; Frigstad SO; Darre-Næss O; Norvard ER; Bolstad N; Kørner H; Wibe A; Wensaas KA; de Lange T; Holme Ø
    Gastroenterology; 2021 Mar; 160(4):1085-1096.e5. PubMed ID: 33227280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
    Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
    J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological effects of colorectal cancer screening: Participants
    Kirkøen B; Berstad P; Botteri E; Bernklev L; El-Safadi B; Hoff G; de Lange T; Bernklev T
    World J Gastroenterol; 2016 Nov; 22(43):9631-9641. PubMed ID: 27920484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes following flexible sigmoidoscopy screening for colorectal cancer in a demonstration screening programme in the UK.
    Robb KA; Lo SH; Power E; Kralj-Hans I; Edwards R; Vance M; von Wagner C; Atkin W; Wardle J
    J Med Screen; 2012 Dec; 19(4):171-6. PubMed ID: 23486697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting.
    Senore C; Ederle A; Fantin A; Andreoni B; Bisanti L; Grazzini G; Zappa M; Ferrero F; Marutti A; Giuliani O; Armaroli P; Segnan N
    J Med Screen; 2011; 18(3):128-34. PubMed ID: 22045821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible Sigmoidoscopy and CT Colonography Screening: Patients' Experience with and Factors for Undergoing Screening-Insight from the Proteus Colon Trial.
    Senore C; Correale L; Regge D; Hassan C; Iussich G; Silvani M; Arrigoni A; Morra L; Segnan N
    Radiology; 2018 Mar; 286(3):873-883. PubMed ID: 29040021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G;
    Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Schneede J; Tveit KM; Hoff G
    JAMA; 2014 Aug; 312(6):606-15. PubMed ID: 25117129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptance of screening for colorectal cancer by flexible sigmoidoscopy.
    Cockburn J; Thomas RJ; McLaughlin SJ; Reading D
    J Med Screen; 1995; 2(2):79-83. PubMed ID: 7497160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer.
    Eloubeidi MA; Wallace MB; Desmond R; Farraye FA
    Am J Gastroenterol; 2003 Jul; 98(7):1634-9. PubMed ID: 12873591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
    Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
    Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of One-off Flexible Sigmoidoscopy with Fecal Immunochemical Testing in a Large Screening Population.
    Niedermaier T; Weigl K; Hoffmeister M; Brenner H
    Epidemiology; 2018 May; 29(3):397-406. PubMed ID: 29287053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
    Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
    Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
    Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.